Navigation Links
Cadila to Commence Phase I Clinical Trials On ZYH2

Cadila Healthcare Ltd today said it has received approval from Drug Controller General of India (DCGI) to conduct Phase I clinical trials on its New Molecular Entity// (NME) - ZYH2, used for treating diabetes.

In pre-clinical studies on 'ZY H2' displayed that it has the potential to improve insulin resistance and lower blood glucose in diabetic conditions without causing hypoglycemia, the company informed the Bombay Stock Exchange.

It also works favourably to lower the elevated lipid levels and the pre-clinical studies on ZYH2 indicate that this NME may be more effective for diabetics, it added.

The shares of the company closed at Rs 545.50, up 0.06 per cent at the BSE.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Zydus Cadila and Kopran in strategic alliance
2. Cadila gets US FDA approval for Promethazine tablets
3. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
4. Face Transplants To Commence In The UK
5. Pfizer Commences Its Advertising for Celebrex with All the Warnings
6. Natco Pharma Commences Production At Dehradun Unit
7. Chinas First Gay Health Clinic Commences Operations
8. Mental Health - NHS Trust Commences Specialist Transition Service
9. SARS-Free Taiwan to Mark End Phase of Global Fight
10. Spray on contraceptive clears Phase I trial
11. Phase 3 trials of two multi-kinase inhibitors against cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... Yes, the Millennials love their Bluetooth ... Council on Active Aging® (ICAA), new tech is also finding a home in senior ... , queried respondents from a variety of organizations that work with older adults about ...
(Date:1/14/2019)... ... 14, 2019 , ... Trees can be overweight too! Giroud Tree and ... and winter is a great time to clean things up on the property! , ... damage, especially during windy or icy storms. The crown of the tree should be ...
(Date:1/13/2019)... ... January 12, 2019 , ... On December 13th, ... Temple University hosted a continuing education (CEU) event entitled, Can You Hear Me ... to create a series of talks to help develop and cultivate the relationship ...
(Date:1/11/2019)... ... January 11, 2019 , ... Ms. ... training in the U.S., alleges that Andrews and others engaged in a systematic ... Andrews disparagingly referred to employees by race and by the color of their ...
(Date:1/10/2019)... ... January 10, 2019 , ... Net-Translators, an ... with MD101, a regulatory consulting company that serves the medical industry. The companies ... companies in the medical device and healthcare industries. Based in France, they join ...
Breaking Medicine News(10 mins):
(Date:1/21/2019)... ... January 21, 2019 , ... With more than 10,000 ... the growth needs of our clients with prompt, effective and cost-efficient installation services of ... operating in four states in the U.S. and two provinces in Canada with additional ...
(Date:1/21/2019)... ... January 21, 2019 , ... Nanomedical ... corporate name change to Cardea , effective January 21, 2019. , The ... serving the pharmaceutical industry with ultra sensitive biosensor research tools, to opening its ...
(Date:1/20/2019)... ... January 18, 2019 , ... The Icahn School of ... drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis (MPS), with Australia-based company ... , MPS is a group of 11 lysosomal storage diseases, metabolic disorders caused ...
Breaking Medicine Technology: